What does Pancreatin do?

Digestive enzyme blend. Clinically proven to aid nutrient absorption in people with pancreatic insufficiency.

Primarily studied in patients with diagnosed pancreatic exocrine insufficiency — benefits in healthy adults are not established by the provided studies

Pancreatin - Science-Based Research

What the Science Says

Pancreatin is a mixture of digestive enzymes — including lipase, protease, and amylase — derived from animal pancreatic tissue. In people whose pancreas cannot produce enough enzymes (such as after pancreatic surgery or with pancreatic cancer), pancreatin replacement therapy has been shown in clinical trials to help maintain body weight, improve protein absorption, and reduce complications like fatty liver disease. High-dose pancreatin (around 40,000 IU per meal, 3x/day) produced meaningful improvements in nutritional markers like prealbumin within 3 months in post-surgical patients.

What It Doesn't Do

Not proven to aid digestion or weight management in healthy people without pancreatic insufficiency. Did not significantly reduce weight loss in unresectable pancreatic cancer patients in a placebo-controlled trial. No evidence it boosts metabolism, burns fat, or improves gut health in people with normal pancreatic function. The digestive enzyme blend in one post-bariatric surgery study showed modest GI symptom improvement, but results were not compared to a true placebo.

Evidence-Based Benefits

Pancreatin is a mixture of digestive enzymes — including lipase, protease, and amylase — derived from animal pancreatic tissue. In people whose pancreas cannot produce enough enzymes (such as after pancreatic surgery or with pancreatic cancer), pancreatin replacement therapy has been shown in clinical trials to help maintain body weight, improve protein absorption, and reduce complications like fatty liver disease. High-dose pancreatin (around 40,000 IU per meal, 3x/day) produced meaningful improvements in nutritional markers like prealbumin within 3 months in post-surgical patients.

Moderate Evidence

Effective at: No established dose for healthy adults; clinical studies used 40,000 IU (3x/day with meals) or 3.0–12.0 g/day in post-surgical patients

Source: auto-research

Absorption & Bioavailability

Unknown for the enzymes themselves as systemic agents — they act locally in the gut. Enteric-coated formulations are designed to survive stomach acid and release in the small intestine, which is critical for efficacy.

Red Flags to Watch For

Primarily studied in patients with diagnosed pancreatic exocrine insufficiency — benefits in healthy adults are not established by the provided studies
Poor compliance significantly undermined outcomes in the largest RCT; real-world effectiveness may be lower than trial results suggest
One RCT in pancreatic cancer patients found no significant benefit over placebo for weight loss or survival — not a universal fix for malnutrition
Most supplement products (950 registered) are marketed for general digestion, but clinical evidence only supports use in pancreatic insufficiency
Derived from animal (typically porcine) pancreatic tissue — not suitable for vegetarians, vegans, or those with religious dietary restrictions